Tech Company M&A Transactions

Helixis Acquisition

On 7/28/2010, Helixis was acquired by Illumina. Illumina said the transaction price was $105 million.

Transaction Overview

Company Name
Acquired By
Announced On
7/28/2010
Transaction Type
M&A
Amount
$105,000,000
M&A Terms
Illumina will acquire Helixis for $70 million in cash upfront, plus another $35 million in contingent considerations.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
5421 Avenida Encinas B
Carlsbad, CA 92008
USA
Email Address
Overview
Diagnostics tools for molecular analysis are critical to modern life science and medicine, but are still primitive in form and function. Helixis is developing an entirely new class of advanced molecular diagnostic products that will bring fast, accurate and low cost diagnostics to a range of critical medical and scientific applications in both the developed and developing worlds.
Profile
Helixis LinkedIn Company Profile
Social Media
Helixis Company Twitter Account
Company News
Helixis News
Facebook
Helixis on Facebook
YouTube
Helixis on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alex Dickinson
  Alex Dickinson LinkedIn Profile  Alex Dickinson Twitter Account  Alex Dickinson News  Alex Dickinson on Facebook
Co-Founder
David Baltimore
  David Baltimore LinkedIn Profile  David Baltimore Twitter Account  David Baltimore News  David Baltimore on Facebook
Co-Founder
Mathew Johnston
  Mathew Johnston LinkedIn Profile  Mathew Johnston Twitter Account  Mathew Johnston News  Mathew Johnston on Facebook
Co-Founder
George Maltezos
  George Maltezos LinkedIn Profile  George Maltezos Twitter Account  George Maltezos News  George Maltezos on Facebook
Vice President
Adrian Fawcett
  Adrian Fawcett LinkedIn Profile  Adrian Fawcett Twitter Account  Adrian Fawcett News  Adrian Fawcett on Facebook
VP - Bus. Development
Sameer Rohatgi
  Sameer Rohatgi LinkedIn Profile  Sameer Rohatgi Twitter Account  Sameer Rohatgi News  Sameer Rohatgi on Facebook
VP - Marketing
Judy Macemon
  Judy Macemon LinkedIn Profile  Judy Macemon Twitter Account  Judy Macemon News  Judy Macemon on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/28/2010: Verient venture capital transaction
Next: 7/28/2010: HemaQuest Pharmaceuticals venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to document funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary